Berberine

Anter

• E kūpono paha no ...
• ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...
• Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

ʻO Berberine kahi kemika i loaʻa i nā mea kanu like me ka barberry European, goldenseal, goldthread, celandine ʻoi aku ka nui, nā hua waina Oregon, phellodendron, a me ka turmeric lāʻau.

Lawe pinepine ʻia ʻo Berberine no ka maʻi diabetes, nā pae kiʻekiʻe o ke kolesterol a i ʻole nā ​​momona ʻē aʻe (lipids) i ke koko (hyperlipidemia), a me ke kiʻekiʻe o ke koko. Hoʻohana ʻia ia no ka puhi ʻana, ka maʻi ʻeha, ka maʻi ate, a me nā ʻano ʻē aʻe he nui akā ʻaʻohe hōʻike ʻepekema maikaʻi e kākoʻo i ka nui o kēia mau hoʻohana.

Nā Laʻau Laʻau Kūlohelohe Kūlohelohe nā helu kūpono e pili ana i nā hōʻike ʻepekema e like me ka pālākiō e hiki mai ana: Ka maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi, ka hopena maikaʻi ʻole, ka maikaʻi ʻole, ka maikaʻi ʻole, a me ka lawa ʻole o nā hōʻike i ka helu.

Nā helu kūpono no BERBERINE penei:

E kūpono paha no ...

• ʻEha ʻo Canker. Hōʻike ka noiʻi i ka noi ʻana i kahi gel i loaʻa i ka berberine hiki ke hoʻēmi i ka ʻeha, ʻulaʻula, kaʻi ʻana, a me ka nui o nā ulcer i nā kānaka me nā maʻi ʻeha.
• Diabetes. Me he mea lā e hoʻoliʻiliʻi iki ʻo Berberine i nā pae kō kō i nā poʻe me ka maʻi kō. Eia kekahi, hōʻike kekahi mau noiʻi mua i ka lawe ʻana i 500 mg o berberine 2-3 mau manawa i kēlā me kēia lā a hiki i 3 mau mahina ke kaohi i ke kō kō e like me ka metformin a i ʻole rosiglitazone.
• Nā pae kiʻekiʻe o ke kolesterol a i ʻole nā ​​momona ʻē aʻe (lipids) i ke koko (hyperlipidemia). Hiki paha iā Berberine ke kōkua i ka hoʻohaʻahaʻa ʻana i nā pae kolesterol i ka poʻe me ke kiʻekiʻe o ke kō. Lawe i ka berberine a hiki i 2 mau makahiki e hoʻoliʻiliʻi i ka nui o ke kōkōlō, lipoprotein haʻahaʻa (LDL a i ʻole "maikaʻi") kolesterol, a me nā pae triglyceride i ka poʻe me ke kiʻekiʻe o ka cholesterol. Ke hoʻohālikelike ʻia me nā lāʻau hoʻohaʻahaʻa kolesterol maʻamau, ʻike ʻia ka berberine e hoʻololi like i ka nui o ke kōkōlō, LDL kolesterol, a me ka lipoprotein kiʻekiʻe (HDL a i ʻole "maikaʻi") kolesterol, a ʻoi aku paha ka maikaʻi o ka hōʻemi ʻana i nā pae triglyceride.
• Piʻi koko kiʻekiʻe. Lawe i ka 0.9 gram o berberine i kēlā lā i kēia lā me ka amlodipine hoʻohaʻahaʻa koko e hoʻemi ana i ke kaomi systolic (ka helu kiʻekiʻe) a me ke kahe o ke koko diastolic (ʻo ka helu lalo) ʻoi aku ka maikaʻi ma mua o ka lawe ʻana i ka amlodipine wale nō i ka poʻe me ke kiʻekiʻe kiʻekiʻe
• ʻO kahi maʻi hormonal nāna e hoʻonui i nā ovaries me nā cist (polycystic ovary syndrome a i ʻole PCOS). Hōʻike ka noiʻi e hiki i ka berberine ke hoʻohaʻahaʻa i ke kō i ke kō, hoʻomaikaʻi i ka pae kolesterol a me nā pae triglyceride, hoʻoliʻiliʻi i nā pae testosterone, a me ka lāki haʻahaʻa o ka pūhaka i kou pūhaka i nā wahine me PCOS. Hiki i ka Berberine ke hoʻohaʻahaʻa i nā pae kō kō e like me ka metformin a hoʻomaikaʻi paha i nā kiʻekiʻe kolesterol ma mua o ka metformin. ʻAʻole maopopo inā hoʻonui ka berberine i nā helu hāpai a i ʻole nā ​​helu hānau ola i nā wahine me PCOS.

ʻAʻole lawa nā hōʻike e hōʻike i ka pono no ...

• Burns. Hōʻike ka noiʻi mua i ka noi ʻana i kahi hamo i loko o ka berberine a me ka beta-sitosterol hiki ke mālama i ka wela ʻelua e like me ka hoʻomaʻamaʻa maʻamau me ka sulfadiazine kālā.
• An maʻiʻaʻai o na naʻau i ke kumu diarrhea (cholera). Hōʻike kekahi o nā noiʻi mua i ka lawe ʻana i berberine sulfate hiki ke hoʻemi i ka diarrhea e kahi mea liʻiliʻi i ka poʻe me ke kolera. Eia naʻe, ʻaʻole maikaʻi ka berberine i nā hopena o ka lāʻau tetracycline antibiotic i ka mālama ʻana i ka maʻi pākē e pili ana i ka maʻi cholera.
• Nā ulu ulu ʻole i loko o ka ʻōpū nui a me ke kīhā (colorectal adenoma). Hōʻike ka noiʻi mua i ka lawe ʻana i berberine no 2 mau makahiki e like me ka pale ʻana i ka ulu hou ʻana o nā adenomas colorectal i ka poʻe i mālama mua ʻia no kēia ulu.
• Kūkulu ka puʻuwai puʻuwai a me ka wai i ke kino (ka puʻuwai puʻuwai a me CHF paha). Hōʻike ka noiʻi mua i hiki i ka berberine ke hōʻemi i kekahi o nā ʻōuli a hoʻohaʻahaʻa i ka nui o ka make ma kekahi poʻe me ka puʻuwai puʻuwai.
• Maʻi maʻi puʻuwai. Hōʻike ka noiʻi i ka lawe ʻana i kahi huahana kikoʻī i loaʻa ka berberine a me nā mea hana ʻē aʻe no 3 mau mahina e hoʻohaʻahaʻa i nā kiʻekiʻe kolesterol i ka poʻe me ka maʻi puʻuwai i loaʻa kahi kaʻina i kapa ʻia he percutaneite interven (PCI). Hoʻohaʻahaʻa kēia huahana i nā pae kolesterol ma mua o ka lāʻau ezetimibe maʻamau, i hoʻohana ʻia e hoʻoliʻiliʻi i ka kolesterol. Lawe pū i kēia huahana me ka hoʻoliʻiliʻi o nā lāʻau o nā lāʻau i kapa ʻia "statins" me he mea lā ʻoi aku ka maikaʻi ma mua o ka lawe ʻana i nā statins haʻahaʻa. ʻAʻole maopopo inā nā hopena o kēia huahana ma muli o berberine, nā mea hoʻohui ʻē aʻe, a i ʻole ka hui ʻana. ʻAʻole maopopo ia inā hoʻemi kēia huahana i ka hopena o nā hanana pili i ka naʻau nui ʻole i ka poʻe me ka maʻi puʻuwai.
• Pohā. Hōʻike kekahi o nā noiʻi mua e hiki i ka berberine sulfate ke hoʻemi i ka maʻi diarrhea i ka poʻe me ka maʻi E. coli.
• ʻO kahi hui o nā maʻi maka e hiki ai ke alakaʻi i ka nalo ʻana o ka ʻike (glaucoma). Hōʻike ka noiʻi mua ʻana i ka hoʻohana ʻana i nā kulu maka me berberine a me tetrahydrozoline ʻaʻole ia e hoʻemi i ke kaomi maka i ka poʻe me ka glaucoma ʻoi aku ka maikaʻi ma mua o nā kulu maka i loaʻa ka tetrahydrozoline wale nō.
• ʻO kahi maʻi maʻi digestive e hiki ai i nā ulcer (Helicobacter pylori a i ʻole H. pylori). Hōʻike ka noiʻi mua i ka lawe ʻana i berberine ʻoi aku ka maikaʻi ma mua o ka ranitidine lāʻau i ka mālama ʻana i ka maʻi H. pylori. Akā ʻoi aku ka maikaʻi o ka berberine i ka hōʻola ʻana i ka maʻi ulcer i ka poʻe me nā puʻupuʻu o ka ʻōpū ma muli o H. pylori. Hōʻike kekahi mau noiʻi ʻē aʻe e mālama paha ka berberine i ka maʻi H. pylori a ʻo ka bismuth lāʻau i ka wā i lawe ʻia me ka regimen lāʻau ʻekolu no ka maʻi H. pylori.
• ʻO ka pehu (pehu) o ke ake i hoʻokumu ʻia e ka maʻi hepatitis B (hepatitis B). Hōʻike ka noiʻi mua e hoʻemi ka berberine i ke kō kō, nā momona o ke koko i kapa ʻia nā triglycerides, a me nā māka o ka hōʻino o ke akepaʻa i ka poʻe me ka maʻi diabetes a me ka hepatitis B.
• ʻO ka pehu (pehu) o ke ake i hoʻokumu ʻia e ka maʻi hepatitis C (hepatitis C). Hōʻike ka noiʻi mua e hoʻemi ka berberine i ke kō kō, nā momona o ke koko i kapa ʻia ʻo triglycerides, a me nā māka o ka hōʻino o ke ake i nā poʻe me ka maʻi diabetes a me ka hepatitis C.
• ʻO kahi maʻi lōʻihi lōʻihi o nā ʻōpū nui e hōʻeha i ka ʻeha o ka ʻōpū (irritable bowel syndrome or IBS). Hōʻike ka noiʻi mua i ka lawe ʻana i kēlā berberine i ʻelua mau manawa i kēlā me kēia lā no 8 mau pule e hōʻemi ai i ka maʻi diarrhea a me ka ʻeha o ka ʻōpū a hoʻomaikaʻi paha i ka maikaʻi o ke ola i ka poʻe me IBS me ka diarrhea.
• Nā ʻōuli o ka menopause. Hōʻike ka noiʻi mua i ka lawe ʻana i kahi hui o berberine a me ka soof isoflavones hiki ke hōʻemi i nā hōʻailona menopausal. Eia naʻe, ʻaʻole maopopo inā e hoʻoliʻiliʻi ka berberine i nā hōʻailona menopausal inā hoʻohana wale ʻia.
• ʻO kahi hui o nā hōʻailona e hoʻonui i ka makaʻi o ka maʻi kō, ka maʻi puʻuwai, a me ka hahau (metabolic syndrome). Hōʻike ka noiʻi mua i ka berberine e hoʻemi i ka papa kuhikuhi kino (BMI), systolic pressure pressure (ka helu kiʻekiʻe), nā momona o ke koko i kapa ʻia nā triglycerides, a me nā pae kō kō i nā poʻe me ka maʻi metabolic. Me he mea lā e hoʻomaikaʻi ai i ka ʻike insulin. Hōʻike nā noiʻi ʻē aʻe i ka lawe ʻana i kahi huahana hui pū me berberine, policosanol, raiki hū ʻulaʻula, folic acid, coenzyme Q10, a me astaxanthin e hoʻomaikaʻi ai i ke kahe o ke koko a me ke kahe o ke koko i ka poʻe me ka maʻi metabolic.
• Kūkulu i ka momona i ke akepaʻa i ka poʻe inu inu liʻiliʻi a ʻaole paha i ka wai ʻona (nonalcoholic fatty fat disease or NAFLD). Hōʻike ka noiʻi mua i ka berberine e hoʻemi i ka momona i loko o ke koko a me nā māka o ka ʻeha o ke ake i nā poʻe me ka maʻi diabetes a me NAFLD. Hōʻike nā noiʻi ʻē aʻe e hiki i ka berberine ke hoʻemi i ka momona i ke ake, nā māka o ka ʻeha o ke ake, a me ke kaumaha i ka poʻe me kēia ʻano. Ke hana nei ʻo Berberine e like me ka lāʻau pioglitazone.
• Ka momona. Hōʻike ka noiʻi mua i ka lawe ʻana i berberine hiki ke hoʻemi i ke kaumaha i ka poʻe obese ma kahi o 5 paona.
• Hoʻopilikia ʻia e ka radiation therapy. Hōʻike kekahi o nā noiʻi mua i ka lawe ʻana i berberine i ka wā o ka radiation therapy hiki ke hōʻemi i ka ʻeha o ka ʻōpū mai ka radiation i nā maʻi e mālama ʻia no ka maʻi ʻaʻai.
• Scarring o nāʻaʻaʻa e ka radiation therapy. Hōʻike kekahi mau noiʻi mua i ka lawe ʻana i berberine i ka wā o ka radiation therapy hiki ke hōʻemi i ka hōʻeha o ka māmā mai ka radiation i nā maʻi e mālama ʻia no ka maʻi ʻaʻai.
• Nā pae haʻahaʻa o nā platelet i ke koko (thrombositopenia). He mea nui nā platelet koko no ka hoʻopili ʻana i ke koko. Hōʻike ka noiʻi mua i ka lawe ʻana i berberine hoʻokahi a i ʻole me prednisolone, hiki ke hoʻonui i ka helu o nā platelet koko i ka poʻe me nā helu platelet haʻahaʻa.
• ʻO kahi maʻi maʻi maka i hoʻokumu ʻia e Chlamydia trachomatis (trachoma). Aia kekahi mau hōʻike e pono paha nā kulu maka i loaʻa ka berberine no ka mālama ʻana i ka trachoma, kahi kumu maʻamau o ka makapō ma nā ʻāina kūkulu.
• ʻO kahi ʻano maʻi maʻi ʻōpū (ulcerative colitis). Hōʻike ka noiʻi mua i ka lawe ʻana i berberine ʻaʻole ia e hoʻomaikaʻi i nā ʻōuli i ka poʻe me ka maʻi ulcerative colitis nāna e lawe i ka mesalamine lāʻau.
• Nā kūlana ʻē aʻe.

Pono nā hōʻike hou aʻe e helu i ka pono o berberine no kēia mau hoʻohana.

Hoʻokumu paha ʻo Berberine i nā puʻuwai puʻuwai ikaika. Kōkua paha kēia i ka poʻe me kekahi ʻano puʻuwai. Hiki iā Berberine ke kōkua i ka hoʻoponopono ʻana pehea e hoʻohana ai ke kino i ke kō i ke koko. Kōkua paha kēia i ka poʻe me ka maʻi kō. Hiki paha iā ia ke pepehi i nā bacteria a hoʻemi i ka pehu.

Ke lawe ʻia e ka waha: ʻO Berberine ʻo SAFE MAU PONO no ka hapanui o nā mākua no ka hoʻohana manawa pōkole. ʻO nā hopena ʻē aʻe e laʻa me ka maʻi diarrhea, constipation, gas, ʻōpū huhū, a me ka ʻeha poʻo.

Ke hoʻopili ʻia i ka ʻili: ʻO Berberine ʻo SAFE MAU PONO no ka hapanui o nā mākua ke hoʻohana ʻia ka wā pōkole.

Nā mālama a me nā ʻōlelo aʻoaʻo kūikawā:

Hāpai a me ka hānai umauma: ʻO ia LIKELY UNSAFE e lawe i ka berberine e ka waha inā ʻoe hāpai. Manaʻo nā kānaka noiʻi hiki i ka berberine keʻaʻa i ka placenta a hōʻeha paha i ka fetus. ʻO Kernicterus, kahi ʻano o ka lolo i hōʻino ʻia, ua ulu i nā pēpē pēpē i hōʻike ʻia i berberine.

ʻO ia kekahi LIKELY UNSAFE e lawe i ka berberine inā ʻoe e hānai umauma ana. Hiki ke hoʻoili ʻia ʻo Berberine i ke keiki pēpē ma o ka waiū umauma, a he mea ʻeha paha ia.

Nā keiki: ʻO ia LIKELY UNSAFE e hāʻawi i ka berberine i nā keiki hānau hou. Hiki iā ia ke kumu i ka kernicterus, kahi ʻano ʻino o ka lolo e hiki ke hana ʻia i nā keiki hānau hou i loaʻa i ka jaundice koʻikoʻi. Ke melemele nei ʻo Jaundice i ka ʻili i hoʻokumu ʻia e ka bilirubin nui i loko o ke koko. ʻO Bilirubin kahi kemika e hana ʻia ke wāwahi nā ʻulaʻula ʻulaʻula. Lawe ʻia ia e ke akepaʻa. Mālama paha ʻo Berberine i ke akepaʻa mai ka lawe koke ʻana i ka bilirubin. ʻAʻole lawa ka ʻike pono e ʻike inā palekana ka berberine i nā keiki makua.

Diabetes: Hiki i ka Berberine ke hoʻohaʻahaʻa i ke kō kō. ʻO ke kumuhana, hiki i ka berberine ke hoʻohaʻahaʻa i ke kō kō inā lawe ʻia e nā diabetic e kaohi ana i kā lākou kō kō me nā insulin a i ʻole nā ​​lāʻau. E hoʻohana me ka akahele i ka poʻe me ka maʻi kō.

Nā pae bilirubin kiʻekiʻe i ke koko i loko o nā pēpē: Bilirubin kahi kemika i hana ʻia ke wā e haki nā hunaola ʻulaʻula kahiko. Lawe ʻia ia e ke akepaʻa. Mālama paha ʻo Berberine i ke akepaʻa mai ka lawe koke ʻana i ka bilirubin. Hiki i kēia ke kumu i nā pilikia o ka lolo, keu hoʻi i nā pēpē me nā kiʻekiʻe o ka bilirubin i ke koko. Pale hoʻohana.

Kaomi haʻahaʻa: Hiki iā Berberine ke hoʻohaʻahaʻa i ke kahe o ke koko. ʻO ke kaulike, hiki i ka berberine ke hoʻonui i ka makaʻu o ke kahe o ke koko i haʻahaʻa loa i ka poʻe i loaʻa ke kaomi haʻahaʻa. E hoʻohana me ka akahele.

Mekia

Mai lawe i kēia hui ʻana.

Cyclosporine (Neoral, Sandimmune)

Hōʻoki ke kino i ka cyclosporine e kāpae iā ia. E hoʻemi paha ʻo Berberine i ka wikiwiki o ka haki o ke kino i ka cyclosporine a kūkulu paha ia i loko o ke kino a hiki paha ke hopena i nā hopena ʻaoʻao.

Kānāwai

E akahele me kēia hui ʻana.

Dextromethorphan (Robitussin DM, kekahi)

Haki ke kino i ka dextromethorphan e hemo ai. E hoʻemi paha ʻo Berberine i ka wikiwiki o ka wāwahi o ke kino iā ia a hoʻonui paha i nā hopena a me nā hopena ʻē aʻe o dextromethorphan.

Losartan (Cozaar)

Hoʻoikaika ke akepaʻa i ka losartan e hana pono. E hoʻemi paha ʻo Berberine i ka wikiwiki o ke kino e hoʻoiho iā ia, a e hōʻemi paha i nā hopena.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 2C9 (CYP2C9) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ʻo Berberine i ka wikiwiki o ka haki o ke ake i kēia mau lāʻau a hoʻonui i nā hopena a me nā hopena ʻaoʻao.

ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa e like me celecoxib (Celebrex), diclofenac (Voltaren), fluvastatin (Lescol), glipizide (Glucotrol), ibuprofen (Advil, Motrin), irbesartan (Avapro), losartan (Cozaar), phenytoin (Dilantin), piroxicam (Feldene), tamoxifen (Nolvadex), tolbutamide (Tolinase), torsemide (Demadex), a me S-warfarin (Coumadin).

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 2D6 (CYP2D6) substrates)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ʻo Berberine i ka wikiwiki o ka haki o ke ake i kēia mau lāʻau a hoʻonui i nā hopena a me nā hopena ʻaoʻao. ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa, ʻo ia hoʻi ʻo amitriptyline (Elavil), codeine, desipramine (Norpramin), flecainide (Tambocor), haloperidol (Haldol), imipramine (Tofranil), metoprolol (Lopressor, Toprol XL), ondansetron (Zofran), paroxetine (Paxil ), risperidone (Risperdal), tramadol (Ultram), venlafaxine (Effexor), a me nā mea ʻē aʻe.

Hoʻololi nā lāʻau i ke ake (Cytochrome P450 3A4 (CYP3A4)

Hoʻololi ʻia kekahi mau lāʻau a wāwahi ʻia e ke ake. E hoʻemi paha ʻo Berberine i ka wikiwiki o ka haki o ke ake i kēia mau lāʻau a hoʻonui i nā hopena a me nā hopena ʻaoʻao. ʻO kekahi mau lāʻau i hoʻololi ʻia e ke akepaʻa ʻo ia ʻo cyclosporin (Neoral, Sandimmune), lovastatin (Mevacor), clarithromycin (Biaxin), indinavir (Crixivan), sildenafil (Viagra), triazolam (Halcion), a me nā mea ʻē aʻe he nui.

Nā lāʻau no ka maʻi kō (Antidiabetes lāʻau)

E hoʻohaʻahaʻa paha ʻo Berberine i ke kō kō. Hoʻohana ʻia nā lāʻau diabetes e hoʻohaʻahaʻa i ke kō kō. Lawe pū i ka berberine me nā lāʻau maʻi diabetes e hoʻohaʻahaʻa ai i kāu kō kō. E nānā pono i kāu kō kō. Pono e hoʻololi i ka mahele lāʻau o kāu lāʻau diabetes.

ʻO kekahi mau lāʻau i hoʻohana ʻia no ka maʻi kō me glimepiride (Amaryl), glyburide (Diabeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), a me nā mea ʻē aʻe.

Nā lāʻau no ke koko kiʻekiʻe (Antihypertensive lāʻau lapaʻau)

Hiki i ka Berberine ke hoʻemi i ke kahe o ke koko i kekahi mau kānaka. Lawe i ka berberine me nā lāʻau i hoʻohana ʻia e hoʻohaʻahaʻa i ke koko kiʻekiʻe e hoʻohaʻahaʻa i kou kahe koko.

ʻO kekahi mau lāʻau no ke koko kiʻekiʻe me captopril (Capoten), enalapril (Vasotec), losartan (Cozaar), valsartan (Diovan), diltiazem (Cardizem), amlodipine (Norvasc), hydrochlorothiazide (HydroDIURIL), furosemide (Lasix), a me nā mea ʻē aʻe he nui. .

Nā lāʻau i hoʻolohi i ke kō ʻana o ke koko (Anticoagulant / Antiplatelet drug)

Hoʻohiʻa paha ʻo Berberine i ke kāpili ʻana o ke koko. Lawe i ka berberine me nā lāʻau lapaʻau e hōʻemi ana i ka hoʻopili ʻana i hoʻonui i nā manawa o ka ʻeha a me ke kahe ʻana.

ʻO kekahi mau lāʻau e lohi ai ke kāpili ʻana o ke koko me aspirin, cilostazol (Pletal), clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), a me nā mea ʻē aʻe.

Metformin (Glucophage)

Hoʻonui paha ʻo Berberine i ka nui o metformin i ke kino. Hiki i kēia ke hoʻonui i nā hopena a me nā hopena ʻaoʻao. Kuhi ʻia kēia pilina ke lawe ʻia ka berberine ma kahi o 2 mau hola ma mua o ka metformin. Lawe ka berberine a me ka metformin i ka manawa like ʻole e hoʻonui i ka nui o ka metformin i ke kino.

Midazolam (Versed)

Haki ke kino i ka midazolam e hemo ai. Hiki i ka Berberine ke hoʻēmi i ka wikiwiki o ke kino e wāwahi iā ia a hoʻonui paha i nā hopena a me nā hopena ʻaoʻao o midazolam.

Pentobarbital (Nembutal)

ʻO Pentobarbital kahi lāʻau e hiki ai ke hiamoe. Hoʻokumu pū paha ʻo Berberine i ka hiamoe a me ka hiamoe. Lawe i ka berberine me ka pentobarbital i mea e nui ai ka hiamoe.

Nā lāʻau lapaʻau hōʻoluʻolu (depressants CNS)

Hoʻokumu paha ʻo Berberine i ka hiamoe a me ka hiamoe. ʻO nā lāʻau i kumu e hiamoe ai i kapa ʻia ʻo nā mea hōʻohi. Lawe i ka berberine me nā lāʻau hoʻohiamoe i kumu e hiamoe nui ai.

ʻO kekahi mau lāʻau hoʻohiehie e komo pū me benzodiazepines, pentobarbital (Nembutal), phenobarbital (Luminal), secobarbital (Seconal), thiopental (Pentothal), fentanyl (Duragesic, Sublimaze), morphine, propofol (Diprivan), a me nā mea ʻē aʻe.

ʻO Tacrolimus (Prograf)

ʻO Tacrolimus kahi lāʻau hoʻomākino. Lawe ʻia i ke kino e ke akepaʻa. E hoʻemi paha ʻo Berberine i ka wikiwiki o ka lawe ʻana o ke kino iā ia a hoʻonui paha kēia i nā hopena a me nā hopena ʻē aʻe o tacrolimus.

ʻO nā lau nahele a me nā mea hoʻopili e hoʻoliʻiliʻi i ke kahe o ke koko

E hoʻohaʻahaʻa paha ʻo Berberine i ke koko. ʻO ka hoʻohana ʻana ia me nā mea kanu a me nā mea hoʻopili ʻē aʻe i loaʻa kēia hopena like e hoʻonui paha i ka makaʻu o ke kahe o ke koko e hāʻule haʻahaʻa ana i kekahi poʻe. ʻO kekahi o kēia huahana me andrographis, casein peptides, claw o ka pōpoki, coenzyme Q-10, aila iʻa, L-arginine, lycium, ʻupena hoʻopuʻupuʻu, theanine, a me nā mea ʻē aʻe.

ʻO nā lau nahele a me nā mea hoʻopili e hoʻoliʻiliʻi ai i ke kō kō

E hoʻohaʻahaʻa paha ʻo Berberine i ke kō kō. ʻO ka hoʻohana ʻana ia me nā mea kanu a me nā mea hoʻopili ʻē aʻe i like ka hopena e hoʻoliʻiliʻi haʻahaʻa i ke kō kō i kekahi poʻe. ʻO kekahi o kēia mau huahana e laʻa me ka alpha-lipoic acid, melon ʻawaʻawa, chromium, māiʻuʻu diabolō, fenugreek, kālika, ʻapi kāpili, hua chestnut lio, ginseng Panax, psyllium, ginseng Siberian, a me nā mea ʻē aʻe.

ʻO nā lau nahele a me nā mea hoʻopili e lohi ai i ke kāpili ʻana o ke koko

Hoʻohiʻa paha ʻo Berberine i ke kāpili ʻana o ke koko. Lawe i ka berberine me nā mea kanu ʻē aʻe e lohi ai i ke kāpili ʻana o ke koko e hoʻonui ai i nā manawa o ka palapū a me ke kahe ʻana o ke kahe. Hoʻopili kēia mau mea kanu me angelica, clove, danshen, kālika, ginger, ginkgo, ginseng Panax, a me nā mea ʻē aʻe.

Nā mea kanu a me nā mea hoʻopihapiha me nā mea hoʻohiamoe

Hiki i ka Berberine ke hana i ka hiamoe a hiamoe paha. Ke hoʻohana nei ia me nā mea kanu a me nā mea hoʻopili ʻē aʻe i like ka hopena e hiamoe nui ʻoe. ʻO kekahi o kēia mau mea kanu a me nā mea hoʻopihapiha me ka calamus, California poppy, catnip, hops, Jamaican dogwood, kava, L-tryptophan, melatonin, sage, SAMe, St. John's wort, sassafras, skullcap, a me nā mea ʻē aʻe.

Nā Probiotics

Loaʻa i nā mea hoʻopili Probiotic i nā bacteria i manaʻo ʻia he mea pono i ke olakino. Pepehi paha ʻo Berberine i kekahi mau ʻano probiotic. Inā lawe pū ʻia, e hoʻoliʻiliʻi paha ka berberine i ka maikaʻi o ka holo ʻana o nā lāʻau probiotic.

ʻAʻole ʻike ʻia nā launa me nā meaʻai.

NA MAKAHIKI

E ka waha:

• No ka maʻi kō: 0.9-1.5 gram o berberine i lawe ʻia i nā mahele i hoʻokaʻawale ʻia i kēlā me kēia lā no 2-4 mau mahina.
• No nā pae kiʻekiʻe o ka kolesterol a i ʻole nā ​​momona ʻē aʻe (lipids) i ke koko (hyperlipidemia): Ua lawe ʻia ʻo 0.6-1.5 gram o berberine i nā mahele i hoʻokaʻawale ʻia i kēlā me kēia lā no 6 a 24 mau mahina. ʻO nā huahana hui pū me 500 mg o berberine, 10 mg o ka polososanol, a me 200 mg laiki hū ʻulaʻula, me nā mea hoʻohui ʻē aʻe, i lawe ʻia i kēlā me kēia lā a hiki i 12 mau mahina.
• No ke koko kiʻekiʻe: Lawe ʻia ʻo 0.9 gram o berberine i kēlā me kēia lā no 2 mau mahina.
• No kahi maʻi hormonal e kumu i nā ovaries i hoʻonui ʻia me nā cista (polycystic ovary syndrome a i ʻole PCOS): Lawe ʻia ʻo 1.5 gram o berberine i kēlā me kēia lā no 3-6 mau mahina.

Noi i ka ili:

• No ka maʻi ʻeha: Hoʻopili ʻia ka gel nona ka 5 mg o berberine no ka gram i ʻehā mau manawa i kēlā me kēia lā no 5 mau lā.

ʻO Alcaloïde de Berbérine, Berberina, Berbérine, Berberine Alkaloid, Berberine Complex, Berberine Sulphate, Sulfate de Berbérine, Umbellatine.

E aʻo hou aʻe ai pehea i kākau ʻia ai kēia ʻatikala, e ʻoluʻolu e ʻike i ka Nā Laʻau Laʻau Kūlohelohe Kūlohelohe ʻano hana.

1. Asbaghi ​​O, Ghanbari N, Shekari M, et al. ʻO ka hopena o ka berberine supplementation ma luna o nā palena momona, ka mumū a me nā ʻenemi hana ate: kahi loiloi ʻōnaehana a me nā meta-analysis o nā hoʻokolohua hoʻokolohua kaulike ʻole ʻia. ʻO Clin Nutr ESPEN 2020; 38: 43-9. Nānā kiʻi ʻole.
2. Chen YX, Gao QY, Zou TH, et al. ʻO Berberine me kahi placebo no ka pale ʻana i ka hoʻi hou ʻana o ka adenoma colorectal: a multicentre, blinded blind, randomized control study. Lancet Gastroenterol Hepatol. 2020; 5: 267-75. Nānā kiʻi ʻole.
3. Beba M, Djafarian K, Shab-Bidar S. Ka hopena o Berberine i ka protein C-reactive: kahi loiloi ʻōnaehana a me ka meta-anamanaʻo i nā hoʻokolohua hoʻokolohua kaulike ʻia. Hoʻohui Ther Med. 2019; 46: 81-6. Nānā kiʻi ʻole.
4. Lyu Y, Zhang Y, Yang M, et al. ʻO nā hana Pharmacokinetic ma waena o metformin a me berberine i nāʻiole: Ke kuleana o nā kaʻina lawelawe waha a me ka microbiota. ʻO Life Sci. 2019; 235: 116818. Nānā kiʻi ʻole.
5. Xu L, Zhang Y, Xue X, et al. ʻO kahi papa I hoʻāʻo o berberine ma Kina me ka ulcerative colitis. Ka maʻi 'aʻai Prev Res (Phila). 2020; 13: 117-26. Nānā kiʻi ʻole.
6. Zhang LS, Zhang JH, Feng R, et al. ʻO ka pono a me ka palekana o berberine wale nō a i ʻole hui pū ʻia me statins no ka mālama ʻana i ka hyperlipidemia: kahi loiloi ʻōnaehana a me nā meta-analysis o nā hoʻokolohua hoʻokolohua kaulike ʻole ʻia. ʻO Am J Chin Med 2019; 47: 751-67. Nānā kiʻi ʻole.
7. Qing Y, Dong X, Hongli L, Yanhui L. Berberine i hoʻolaha i ka pale myocardial o nā mea maʻi ma hope o ka hoʻoponopono ʻana i ka autophagy myocardial. Mea lāʻau lāʻau Biomed. 2018; 105: 1050-1053. Nānā kiʻi ʻole.
8. Ju J, Li J, Lin Q, Xu H. Ka hoʻokō ʻana a me ka palekana o berberine no ka dislipidaemias: He ʻōnaehana loiloi a me nā meta-aniani o nā hoʻokolohua hoʻokolohua kaulike ʻia. Phytomedicine. 2018; 50: 25-34. Nānā kiʻi ʻole.
9. Li G, Zhao M, Qiu F, Sun Y, Zhao L. Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: a open-label, randomized, parallel study in health Chinese kaupapa. ʻO Kauka Des Devel Ther. 2018; 13: 129-139. Nānā kiʻi ʻole.
10. Yan HM, Xia MF, Wang Y, Chang XX, Yao XZ, Rao SX, et al. Ka hopena o berberine i nā mea maʻi me ka maʻi ʻona ʻona ʻona ʻona ʻole. PLoS Hoʻokahi. 2015 Aug 7; 10: e0134172. hana: 10.1371 / journal.pone.0134172. Nānā kiʻi ʻole.
11. Chen C, Tao C, Liu Z, Lu M, Pan Q, Zheng L, et al. ʻO kahi hoʻokolohua hoʻokolohua kaulike ʻia o berberine hydrochloride i nā mea maʻi me ka maʻi diarrhea-preominant irritable bowel syndrome. ʻO Phytother Res. 2015 Nov; 29: 1822-7. hana: 10.1002 / ptr.5475. Nānā kiʻi ʻole.
12. Wu XK, Wang YY, Liu JP, Liang RN, Xue HY, Ma HX, et al. Hoʻomaʻamaʻa kaulike ʻia o ka letrozole, berberine, a i ʻole ka hui pū ʻana no ka infertility i ka polycystic ovary syndrome. Fertil Steril. 2016; 106: 757-765.e1. hana: 10.1016 / j.fertnstert.2016.05.022. Nānā kiʻi ʻole.
13. Zhang D, Ke L, Ni Z, Chen Y, Zhang LH, Zhu SH, et al. ʻO Berberine i loaʻa ka quadruple therapy no ka Helicobacter pylori eradication mua: kahi hāmama hāpana IV i hoʻāʻo ʻia. Lapaʻau (Baltimore). 2017; 96: e7697. hana: 10.1097 / MD.0000000000007697. Nānā kiʻi ʻole.
14. Marazzi G, Campolongo G, Pelliccia F, Quattrino S, Vitale C, Cacciotti L, et al. Hoʻohālikelike o ka statin dose haʻahaʻa me statin haʻahaʻa-dosis + Armolipid a me nā mea maʻi statin-intolerant kiʻekiʻe me ka hanana coronary mua a me ka internaon coronary percutaneus (ADHERENCE trial). ʻO Am J Cardiol. 2017 Sep 15; 120: 893-897. hana: 10.1016 / j.amjcard.2017.06.015. Nānā kiʻi ʻole.
15. Marazzi G, Pelliccia F, Campolongo G, Quattrino S, Cacciotti L, Volterrani M, et al. ʻO ka pono o nā meaola nutritional (Armolipid Plus) me ezetimibe a me ka hui pū ʻana i nā mea hoʻomanawanui ʻole statin me ka dyslipidemia me nā maʻi puʻuwau coronary. ʻO Am J Cardiol. 2015 Dec 15; 116: 1798-801. hana: 10.1016 / j.amjcard.2015.09.023. Nānā kiʻi ʻole.
16. ʻO Wen C, Wu L, Fu L, Zhang X, Zhou H. Berberine e hoʻonui i ka hana anti tumant o tamoxifen i ka MCF 7 a me nā cell MCF 7 / TAM. Mol Med Rep. 2016; 14: 2250-6. Nānā kiʻi ʻole.
17. Millán J, Cicero AF, Torres F, Anguera A. Nā hopena o kahi hui nutritional i loaʻa me berberine (BRB), policosanol, a me ka laiki hū ʻulaʻula (RYR), ma ka hōʻike lipid i nā mea maʻi hypercholesterolemic ʻO Clin Investig Arterioscler. 2016; 28: 178-87. Nānā kiʻi ʻole.
18. ʻO Pérez-Rubio KG, ʻo González-Ortiz M, ʻo Martínez-Abundis E, ʻo Robles-Cervantes JA, ʻo Espinel-Bermúdez MC. Ka hopena o ka lawelawe ʻana o berberine i ka maʻi maʻi metabolic, ka ʻike insulin, a me ka huna ʻana o ka insulin. Metab Syndr Relat Disord 2013; 11: 366-9. Nānā kiʻi ʻole.
19. Lan J, Zhao Y, Dong F, et al. Meta-Ka Ikepili o ka hopena a me ka palekana o berberine i ka mālama ʻana i ka maʻi maʻamau o 2 diabetes, hyperlipemia a me hypertension. ʻO J Ethnopharmacol. 2015; 161: 69-81. Nānā kiʻi ʻole.
20. Jiang XW, Zhang Y, Zhu YL, et al. Nā hopena o berberine gelatin ma luna o ka aphthous stomatitis hou: kahi hoʻokolohua, kahi placebo-kāohi ʻia, hoʻokolokolo makapō pālua i kahi koina Pākē. ʻOihana ʻoki ʻoki ʻlelo Lōpō Lōpō Laha Lōhaola oral 2013; 115: 212-7. Nānā kiʻi ʻole.
21. Hou Q, Han W, Fu X. ʻO ka launa ʻana o ka Pharmacokinetic ma waena o tacrolimus a me berberine i kahi keiki me ka idiopathic nephrotic syndrome. Eur J Clin Pharmacol 2013; 69: 1861-2. Nānā kiʻi ʻole.
22. Dong H, Zhao Y, Zhao L, Lu F. Nā hopena o berberine ma luna o nā lipids koko: kahi ʻōnaehana loiloi a me nā meta-analysis o nā hoʻokolohua hoʻokolohua kaulike ʻia. Planta Med 2013; 79: 437-46. Nānā kiʻi ʻole.
23. An Y, Sun Z, Zhang Y, Liu B, Guan Y, Lu M. Ka hoʻohana ʻana i berberine no nā wahine me ka polycystic ovary syndrome e mālama nei iā IVF. ʻO Clin Endocrinol (Oxf) 2014; 80: 425-31. Nānā kiʻi ʻole.
24. Abascal K, Yarnell E. Nā holomua o ke olakino hou me berberine. Hoʻohui Hoʻohui Ther 2010; 16: 281-7.
25. Huang CG, Chu ZL, Wei SJ, Jiang H, Jiao BH. Ka hopena o berberine ma ka metabolism acid arachidonic i loko o nā pāpaʻi lāpaki a me nā pūnaewele endothelial. ʻO Thromb Res 2002; 106 (4-5): 223-7. Nānā kiʻi ʻole.
26. ʻO Garber AJ. Nā agonists receptor 1 like loa me ka glucagon-like peptide: he loiloi i ko lākou pono a me ka hoʻomanawanui. Mālama Diabetes 2011; 34 Hōʻuluʻulu 2: S279-84. Nānā kiʻi ʻole.
27. Coughlan KA, Valentine RJ, Ruderman NB, Saha AK. Hoʻāʻo AMPK: kahi māka lāʻau no ka maʻi diabetes type 2? ʻO Diabetes Metab Syndr Obes 2014; 7: 241-53. Nānā kiʻi ʻole.
28. ʻO Butcher NJ, Minchin RF. Arylamine N-acetyltransferase 1: kahi māka lāʻau i loko o ka ulu ʻana o ka maʻi ʻaʻai. ʻO Rev. Pharmacol Rev 2012; 64: 147-65. Nānā kiʻi ʻole.
29. ʻO Ruscica M, Gomaraschi M, Mombelli G, Macchi C, Bosisio R, Pazzucconi F, Pavanello C, Calabresi L, Arnoldi A, Sirtori CR, ʻo Magni P. Nutritional hoʻokokoke ʻana e hoʻohaʻahaʻa i ka pilikia cardiometabolic: nā hopena o kahi randomized, double-blind and crossover. hoʻopaʻa me Armolipid Plus. J Clin Lipidol. 2014; 8: 61-8. Nānā kiʻi ʻole.
30. ʻO Rabbani G. ʻO ka hana a me ka mālama ʻana i ka maʻi diarrhea ma muli o Vibrio cholerae a me Escherichia coli: nā hana o nā lāʻau a me nā prostaglandins. Bulletin Lapaʻau Denemaka 1996; 43: 173-185.
31. Kaneda Y, Torii M, Tanaka T, and et al. Nā hopena vitro o berberine sulphate i ka ulu a me ke ʻano o Entamoeba histolytica, Giardia lamblia a me Trichomonas vaginalis. Nā Annals o Tropical Medicine a me Parasitology 1991; 85: 417-425.
32. ʻO Saksena HC, ʻo Tomar VN, a ʻo Soangra MR. Ka hopena o kahi paʻakai hou o Berberine Uni-Berberine i ka ʻeha hikina. Hana Lapaʻau o kēia manawa 1970; 14: 247-252.
33. Purohit SK, Kochar DK, Lal BB, a me et al. ʻO ka mahi ʻana o Leishmania tropica mai nā hihia i hana ʻole ʻia a mālama ʻia hoʻi o ka ʻeha kūmole. Ka Nūpepa India o ke olakino lehulehu 1982; 26: 34-37.
34. Sharma R, Joshi CK, a me Goyal RK. Tanberate Berberine i ka maʻi diarrhea nui. Nā Pediatrics India 1970; 7: 496-501.
35. Li XB. [Hoʻokolohua hoʻokolohua hoʻokolohua i nā pēpē a me nā keiki e hoʻohālikelike ana i nā sachet Lacteol Fort me nā lāʻau kuhikuhi antidiarrhoeal ʻelua]. Ann Pediatr 1995; 42: 396-401.
36. Lahiri S a me Dutta NK. ʻO Berberine a me chloramphenicol i ka mālama ʻana i ka cholera a me ka maʻi nui o ka maʻi. Ka Nūpepa o ka Hui Lapaʻau India 1967; 48: 1-11.
37. Kamat SA. Nā ho'āʻo hoʻokolohua me ka berberine hydrochloride no ka kaohi o ka maʻi diarrhea i ka gastroenteritis huehue. ʻO J Assoc Kauka India India 1967; 15: 525-529.
38. ʻO Dutta NK a me Panse MV. ʻO ka pono o berberine (kahi alkaloid mai Berberis aristata) i ka mālama ʻana i ka cholera (hoʻokolohua). ʻO Indian J Med Res 1962; 50: 732-736.
39. ʻO Wu, S. N., Yu, H. S., Jan, C. R., Li, H. F., a me Yu, C. L. Nā hopena o ka berberine ma nā kahe potassium a me ka calcium i hoʻoheheʻe ʻia i loko o nā hunaʻi myeloma kanaka. Life Sci 1998; 62: 2283-2294. Nānā kiʻi ʻole.
40. Ozaki, Y., Suzuki, H., a me Satake, M. [Hoʻohālikelike i ka noʻonoʻo o ka berberine i ka plasma ma hope o ka lawelawe waha ʻana o ka coptidis rhizoma extract, kona mau hunaola i hoʻomeheu ʻia, a me ka hoʻohana pū ʻana o kēia mau extract a me ka glycyrrhizae radix extract i nāʻiole] . Yakugaku Zasshi 1993; 113: 63-69. Nānā kiʻi ʻole.
41. Hu, F. L. [Hoʻohālikelike o ka waikawa a me Helicobacter pylori i ka ulcerogenesis o ka maʻi ulcer duodenal ulcer]. Zhonghua Yi.Xue.Za Zhi. 1993; 73: 217-9, 253. Nānā i ka abstract.
42. ʻO Arana, B. A., Navin, T. R., Arana, F. E., Berman, J. D., a me Rosenkaimer, F. Ka hopena o kahi papa pōkole (10 mau lā) o ka meglumine antimonate me ka ʻole interferon-gamma i ka mālama ʻana i nā leishmaniasis cutaneous ma Guatemala. ʻOhana Infect Dis 1994; 18: 381-384. Nānā kiʻi ʻole.
43. Chekalina, S. I., Umurzakova, R. Z., Saliev, K. K., a me Abdurakhmanov, T. R. [Ka hopena o ka berberine bisulfate ma ka platelet hemostasis ma nā maʻi thrombositopenia]. Gematologiia i Transfuziologiia 1994; 39: 33-35. Nānā kiʻi ʻole.
44. Ni, Y. X., Yang, J., a me Fan, S. [Haʻawina hoʻokolohua ma jiang tang san i ka mālama ʻana i nā mea maʻi diabetes non-insulin dependant]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1994; 14: 650-652. Nānā kiʻi ʻole.
45. Kuo, C. L., Chou, C. C., a me Yung, B. Y. ʻO Berberine complexes me DNA i loko o ka beroptine-i hoʻokomo ʻia apoptosis i loko o nā leukemia HL-60 pūnaewele. Kaʻu Lett 7-13-1995; 93: 193-200. Nānā kiʻi ʻole.
46. Miyazaki, H., Shirai, E., Ishibashi, M., Hosoi, K., Shibata, S., a me Iwanaga, M. Quantitation o berberine chloride i ka mimi kanaka ma o ka hoʻohana ʻia ʻana o ka nānā ion i ke ʻano desorption kahua. ʻO Biomed.Mass Spectrom. 1978; 5: 559-565. Nānā kiʻi ʻole.
47. Babbar, O. P., Chhatwal, V. K., Ray, I. B., a me Mehra, M. K. Ka hopena o nā maka berberine chloride i heleleʻi i nā mea maʻi trachoma maikaʻi. ʻO India J Med Res. 1982; 76 Hōʻawi: 83-88. Nānā kiʻi ʻole.
48. Mahajan, V. M., Sharma, A., a me Rattan, A. He hana antimycotic o berberine sulphate: he alkaloid mai kahi lau nahele lāʻau India. Sabouraudia. 1982; 20: 79-81. Nānā kiʻi ʻole.
49. Mohan, M., Pant, C. R., Angra, S. K., a me Mahajan, V. M. Berberine i trachoma. (Kahi hoʻokolohua hoʻokolohua). ʻO India J Ophthalmol. 1982; 30: 69-75. Nānā kiʻi ʻole.
50. Tai, Y. H., Feser, J. F., Marnane, W. G., a me Desjeux, J. F. Antisecretory hopena o berberine i ka iole ileum. 'Am J Physiol 1981; 241: G253-G258. Nānā kiʻi ʻole.
51. Chun YT, Yip TT, Lau KL, a me et al. ʻO kahi noiʻi biochemical e pili ana i ka hopena hypotensive o berberine i nāʻiole. ʻO Gen Pharmac 1979; 10: 177-182. Nānā kiʻi ʻole.
52. Desai, A. B., Shah, K. M., a me Shah, D. M. Berberine i ka mālama ʻana i ka maʻi pākī. ʻO Pediatr India. 1971; 8: 462-465. Nānā kiʻi ʻole.
53. Khin, Maung U., Myo, Khin, Nyunt, Nyunt Wai, Aye, Kyaw, a me Tin, U. Hoʻokolokolo hoʻokolokolo o berberine i loko o ka wai nui diarrhea. Br.Med.J. (Clin.Res.Ed) 12-7-1985; 291: 1601-1605. Nānā kiʻi ʻole.
54. Khin, Maung U., Myo, Khin, Nyunt, Nyunt Wai, a me Tin, U. Hoʻokolokolo hoʻokolokolo o ka berberine kiʻekiʻe a me ka tetracycline i cholera. ʻO J Diarrheal Dis Res 1987; 5: 184-187. Nānā kiʻi ʻole.
55. Thumm, H. W. a me Tritschler, J. [Ka hana a Berberin-hāʻule ma ke kaomi intraocular (IOP) (mea kākau unuhi)]. Klin.Monbl.Augenheilkd. 1977; 170: 119-123. Nānā kiʻi ʻole.
56. Albal, M. V., Jadhav, S., a me Chandorkar, A. G. ʻO ka loiloi lāʻau lapaʻau o berberine i nā maʻi mycotic. ʻO India J Ophthalmol. 1986; 34: 91-92. Nānā kiʻi ʻole.
57. Wang, N., Feng, Y., Cheung, F., Chow, OY, Wang, X., Su, W., a me Tong, Y. Ke aʻo hoʻohālikelike e pili ana i ka hana hepatoprotective o ka bile bear a me Coptidis Rhizoma wai i lawe ʻia ma fibrosis ate ma nā ʻiole. BMC. Hoʻohui Hou. Ma 2012, 12: 239. Nānā kiʻi ʻole.
58. ʻO Pisciotta, L., Bellocchio, A., a me Bertolini, S. Nutraceutical pill i loaʻa ka berberine me ezetimibe ma ka plasma lipid kumu i nā kumuhana hypercholesterolemic a me kāna hopena hoʻohui i nā mea maʻi me ka hypercholesterolemia ʻohana ma ka mālama pono ʻana i ka hoʻohaʻahaʻa kolesterol. ʻO Lipids Health Dis 2012; 11: 123. Nānā kiʻi ʻole.
59. Trimarco, V., Cimmino, CS, Santoro, M., Pagnano, G., Manzi, MV, Piglia, A., Giudice, CA, De, Luca N., a me Izzo, R. Nā Nutraceuticals no ka kaohi kaomi koko i nā maʻi. me ke kiʻekiʻe-maʻamau a papa 1 kiʻekiʻe kiʻekiʻe. ʻO ke kiʻekiʻe kiʻekiʻe Press Cardiovasc.Prev. 9-1-2012; 19: 117-122. Nānā kiʻi ʻole.
60. Hayasaka, S., Kodama, T., a me Ohira, A. nā lāʻau lapaʻau Kepanī (kampo) kuʻuna a me ka mālama ʻana i nā maʻi ocular: he loiloi. 'Am J Chin Med 2012; 40: 887-904. Nānā kiʻi ʻole.
61. ʻO Hermann, R. a me von, Richter O. Nā hōʻike hōʻike maʻi o nā lāʻau lāʻau e like me nā mea hana i nā launa lāʻau pharmakokinetic. Planta Med 2012; 78: 1458-1477. Nānā kiʻi ʻole.
62. Hu, Y., Ehli, EA, Kittelsrud, J., Ronan, PJ, Munger, K., Downey, T., Bohlen, K., Callahan, L., Munson, V., Jahnke, M., Marshall, LL, Nelson, K., Huizenga, P., Hansen, R., Soundy, TJ, a me Davies, GE Lipid-hoʻohaʻahaʻa hopena o berberine i nā kumuhana a me nāʻiole. Phytomedicine. 7-15-2012; 19: 861-867. Nānā kiʻi ʻole.
63. ʻO Carlomagno, G., Pirozzi, C., Mercurio, V., Ruvolo, A., a me Fazio, S. Nā hopena o kahi hui nutritional hui ʻana i ka hana hou ʻana o ka ventricular hema a me ka vasoreactivity i nā kumuhana me ka metabolic syndrome. Nutr Metab Cardiovasc. Hōʻalua 2012; 22: e13-e14. Nānā kiʻi ʻole.
64. Cianci, A., Cicero, A. F., Colacurci, N., Matarazzo, M. G., a me De, Leo, V. ʻO ka hana o isoflavones a me berberine ma nā ʻōuli vasomotor a me ka pili lipid i nā wahine menopausal. ʻO Gynecol. Endocrinol. 2012; 28: 699-702. Nānā kiʻi ʻole.
65. Xie, X., Meng, X., Zhou, X., Shu, X., a me Kong, H. [Ke noiʻi e pili ana i ka hopena therapeutic a me ka hemorrheology hoʻololi o berberine i nā mea maʻi hou i ʻike ʻia me ka maʻi diabetes ʻano 2 e hui pū nei i nā maʻi akepaʻa momona nonalcoholic].Zhongguo Zhong Yao Za Zhi 2011; 36: 3032-3035. Nānā kiʻi ʻole.
66. Meng, S., Wang, L. S., Huang, Z. Q., Zhou, Q., Sun, Y. G., Cao, J. T., Li, Y. G., a me Wang, C. Q. Berberine ameliorates mumū i nā mea maʻi me ka huʻi coronary syndrome ma hope percutaneona coronary interven. ʻO Clin Exp. Pharmacol Physiol 2012; 39: 406-411. Nānā kiʻi ʻole.
67. ʻO Kim, H. S., Kim, M. J., Kim, E. J., Yang, Y., Lee, M. S., a me Lim, ʻo J. S. Berberine i hoʻokomo ʻia ʻo AMPK e kāpae i ka hiki metastatic o nā hunaola melanoma ma o ka hoʻemi ʻana i ka hana ERK a me ka COX-2 protein protein. ʻO Biochem. Farmarmol 2-1-2012; 83: 385-394. Nānā kiʻi ʻole.
68. Marazzi, G., Cacciotti, L., Pelliccia, F., Iaia, L., Volterrani, M., Caminiti, G., Sposato, B., Massaro, R., Grieco, F., a me Rosano, G. Nā hopena wā lōʻihi o nā nutraceuticals (berberine, laiki hū ʻulaʻula, policosanol) i nā mea maʻi hypercholesterolemia ʻelemakule. Adv.Ther 2011; 28: 1105-1113. Nānā kiʻi ʻole.
69. Wei, W., Zhao, H., Wang, A., Sui, M., Liang, K., Deng, H., Ma, Y., Zhang, Y., Zhang, H., and Guan, Y. ʻO kahi noiʻi hoʻokolohua e pili ana i ka hopena pōkole o berberine i ka hoʻohālikelike ʻana i ka metformin ma ke ʻano metabolic o nā wahine me ka polycystic ovary syndrome. Eur J Endocrinol. 2012; 166: 99-105. Nānā kiʻi ʻole.
70. Wang, Q., Zhang, M., Liang, B., Shirwany, N., Zhu, Y., a me Zou, MH Hoʻoikaika ʻia ka AMP-activated protein kinase no ka berberine i hoʻokomo ʻia i atherosclerosis i nāʻiole: ke kuleana o ka protein hoʻohui ʻole 2. PLoS.One. 2011; 6: e25436. Nānā kiʻi ʻole.
71. ʻO Guo, Y., Chen, Y., Tan, Z. R., Klaassen, C. D., a me Zhou, H. H. ʻO ka hana pinepine ʻana o berberine e kāpae i nā cytochromes P450 i loko o nā kānaka. Eur J Clin Pharmacol 2012; 68: 213-217. Nānā kiʻi ʻole.
72. Lamb, JJ, Holick, MF, Lerman, RH, Konda, VR, Minich, DM, Desai, A., Chen, TC, Austin, M., Kornberg, J., Chang, JL, Hsi, A., Bland, ʻO JS, a me Tripp, ML Nutritional supplementation of hop rho iso-alpha acid, berberine, vitamin D, a me ka huaʻai K e hoʻopuka nei i kahi pilikino maikaʻi o ka iwi biomarker e kākoʻo ana i ka metabolism iwi maikaʻi i nā wahine postmenopausal me ka maʻi metabolic Nutr Res 2011; 31: 347-355. Nānā kiʻi ʻole.
73. Holick, MF, Lamb, JJ, Lerman, RH, Konda, VR, Darland, G., Minich, DM, Desai, A., Chen, TC, Austin, M., Kornberg, J., Chang, JL, Hsi, A., Bland, JS, a me Tripp, ML Hop rho iso-alpha acid, berberine, wikamina D3 a me ka wikamina K1 e hoʻopili maikaʻi i nā biomarkers o ka hoʻohuli iwi i nā wahine postmenopausal i ka 14 mau pule. ʻO J Bone Miner. Metab 2010; 28: 342-350. Nānā kiʻi ʻole.
74. Zhang, H., Wei, J., Xue, R., Wu, JD, Zhao, W., Wang, ZZ, Wang, SK, Zhou, ZX, Mele, DQ, Wang, YM, Pan, HN, Kong, ʻO WJ, a me Jiang, ʻo JD Berberine e hoʻohaʻahaʻa i ka glucose koko i ka poʻe maʻi diabetes type 2 ma o ka hoʻonui ʻana i ka manaʻo o ka receptor insulin. Metabolism 2010; 59: 285-292. Nānā kiʻi ʻole.
75. Wang, Y., Jia, X., Ghanam, K., Beaurepaire, C., Zidichouski, J., a me Miller, L. Berberine a me nā stanols mea kanu synergistically e kāohi i ka lawe ʻana o ka kolesterol i nā hamsters. Atherosclerosis 2010; 209: 111-117. Nānā kiʻi ʻole.
76. Li, GH, Wang, DL, Hu, YD, Pu, P., Li, DZ, Wang, WD, Zhu, B., Hao, P., Wang, J., Xu, XQ, Wan, JQ, Zhou, ʻO YB, a me Chen, ZT Berberine e kāohi i ka radiation radiation usus i ke kanaka me ka radiotherapy ʻōpū. ʻO Med Oncol. 2010; 27: 919-925. Nānā kiʻi ʻole.
77. ʻO Affuso, F., Ruvolo, A., Micillo, F., Sacca, L., a me Fazio, S. Nā hopena o kahi hui nutrutrial (berberine, raiki hū ʻulaʻula a me nā polososanol) ma nā pae lipid a me ka hana endothelial i hoʻonohonoho ʻia, pālua makapō. , hoʻopaʻa haʻawina placebo-kāohi ʻia. Nutr Metab Cardiovasc. Hoʻomaha 2010; 20: 656-661. Nānā kiʻi ʻole.
78. ʻO Jeong, H. W., Hsu, K. C., Lee, J. W., Ham, M., Huh, J. Y., Shin, H. J., Kim, W. S., a me Kim, ʻo J. B. Berberine e kāpae i nā pane proinflam inflammatory ma o ka hoʻoulu ʻana o AMPK i macrophages. ʻO Am J Physiol Endocrinol. Metab 2009; 296: E955-E964. Nānā kiʻi ʻole.
79. ʻO Kim, WS, Lee, YS, Cha, SH, Jeong, HW, Choe, SS, Lee, MR, Oh, GT, Park, HS, Lee, KU, Lane, MD, a me Kim, ʻo JB Berberine e hoʻomaikaʻi i ka lipid disregulation i ka momona. e ka kaohi ʻana i ka hana AMPK kikowaena a me ka peripheral. ʻO Am J Physiol Endocrinol. Metab 2009; 296: E812-E819. Nānā kiʻi ʻole.
80. Lu, SS, Yu, YL, Zhu, HJ, Liu, XD, Liu, L., Liu, YW, Wang, P., Xie, L., a me Wang, hoʻolaha ʻo GJ Berberine i ka peptide-1 like me glukagon (7- 36) hūnā amide i nā ʻiole diabetic i hoʻokomo ʻia i loko o streptozotocin. J Kukahiko. 2009; 200: 159-165. Nānā kiʻi ʻole.
81. Liu, Y., Yu, H., Zhang, C., Cheng, Y., Hu, L., Meng, X., a me Zhao, Y. Nā hopena pale o berberine i ka hōʻeha ʻana o ka māmā i hoʻokomo ʻia e ka radiation ma o ka mole adhesion. 1 a me ka hoʻololi ʻana i ka mea ulu-beta-1 i nā mea maʻi me ka maʻi ʻaʻai pūpū. ʻO Eur J Cancer 2008; 44: 2425-2432. Nānā kiʻi ʻole.
82. Yang, Z., Shao, YC, Li, SJ, Qi, JL, Zhang, MJ, Hao, W., a me Jin, GZ ʻO ka lāʻau o l-tetrahydropalmatine e hoʻonui nui i ka makemake o ka opiate a hoʻonui i ka helu abstinence i nā mea hoʻohana heroin: kahi pailaka hoʻopaʻa haʻawina. ʻO Acta Pharmacol Sin. 2008; 29: 781-788. Nānā kiʻi ʻole.
83. Zhou, JY, Zhou, SW, Zhang, KB, Tang, JL, Guang, LX, Ying, Y., Xu, Y., Zhang, L., a me Li, DD Nā hopena mau o berberine i ke koko, ka metabolism akepau glucolipid a me ate ʻōlelo PPAR i nā ʻiole hyperlipidemic diabetic. ʻO Biol Pharm Bull. 2008; 31: 1169-1176. Nānā kiʻi ʻole.
84. ʻO Yin, J., Xing, H., a me Ye, J. Ka maikaʻi o berberine i nā mea maʻi me ka maʻi diabetes type 2. Metabolism 2008; 57: 712-717. Nānā kiʻi ʻole.
85. Zhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., Ren, G., a me Ning, G. Ka mālama ʻana i ka maʻi diabetes ʻano 2 a me ka dislipidemia me ka berberine alkaloid maoli. ʻO J Clin Endocrinol. Metab 2008; 93: 2559-2565. Nānā kiʻi ʻole.
86. ʻO Xu, M. G., Wang, J. M., Chen, L., Wang, Y., Yang, Z., a me Tao, ʻo J. Berberine i hoʻouluulu ʻia o nā cell progenitor e holo nei e hoʻomaikaʻi i ka liʻiliʻi o ke aʻa o ke kanaka. J Hum. Hypertens 2008; 22: 389-393. Nānā kiʻi ʻole.
87. Xin, H. W., Wu, X. C., Li, Q., Yu, A. R., Zhong, M. Y., a me Liu, Y. Y. Nā hopena o berberine i nā pharmacokinetics o cyclosporin A i nā limahana olakino olakino. E ʻike i nā hana. Exp. Clin Pharmacol 2006; 28: 25-29. Nānā kiʻi ʻole.
88. ʻO Mantena, S. K., Sharma, S. D., a me Katiyar, S. K. Berberine, kahi huahana kūlohelohe, hoʻonāukiuki i ka hopu ʻia ʻana o ka pūnaewele G1-phase a me ka apoptosis dependant caspase-3-dependant i nā cell carcinoma prostate kanaka. Mol Cancer Ther 2006; 5: 296-308. Nānā kiʻi ʻole.
89. Lin, C. C., Kao, S. T., Chen, G. W., Ho, H. C., a me Chung, J. G. Apoptosis o nā leukemia kanaka HL-60 a me nā leukemia murine WEHI-3 i hoʻoulu ʻia e berberine ma o ka hoʻoulu ʻana o caspase-3. Anticancer Res 2006; 26 (1A): 227-242. Nānā kiʻi ʻole.
90. Lin, J. P., Yang, J. S., Lee, J. H., Hsieh, W. T., a me Chung, J. G. Berberine e hoʻohuli i ka paʻa o ka uila a me ka apoptosis i ka lāhui gastric carcinoma SNU-5 pūnaewele. Honua J Gastroenterol. 1-7-2006; 12: 21-28. Nānā kiʻi ʻole.
91. Inoue, K., Kulsum, U., Chowdhury, S. A., Fujisawa, S., Ishihara, M., Yokoe, I., a me Sakagami, H. Tumor-kikoʻī cytotoxicity a me ka apoptosis-hoʻokomo i ka hana o berberines. Anticancer Res 2005; 25 (6B): 4053-4059. Nānā kiʻi ʻole.
92. Lee, S., Lim, H. J., Park, H. Y., Lee, K. S., Park, J. H., a me Jang, Y. Berberine e kāpae i ka ʻelala vaskular musone cell cell proliferation and migration in vitro a hoʻomaikaʻi i ka neointima hoʻokumu ma hope o ka baluna ʻeha i vivo. Hoʻomaikaʻi ʻo Berberine i ka hoʻokumu neointima i kahi hoʻohālikelike iole. Atherosclerosis 2006; 186: 29-37. Nānā kiʻi ʻole.
93. Kuo, C. L., Chi, C. W., a me Liu, T. Y. Hoʻololi o apoptosis e berberine ma o ka pāpā ʻana i ka cyclooxygenase-2 a me ka ʻōlelo Mcl-1 i nā hunaola maʻi ʻaʻai waha. I Vivo 2005; 19: 247-252. Nānā kiʻi ʻole.
94. Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., ʻO Wang, S., Wu, J., Wang, Y., Li, Z., Liu, J., a me Jiang, ʻo JD Berberine kahi lāʻau hoʻoliʻiliʻi kolesterol hou e hana nei ma o kahi ʻano hana ʻokoʻa i nā statins. Nat Med 2004; 10: 1344-1351. Nānā kiʻi ʻole.
95. Yount, G., Qian, Y., Moore, D., Basila, D., West, J., Aldape, K., Arvold, N., Shalev, N., and Haas-Kogan, D. Berberine sensitizes human nā pūnaewele glioma, akā ʻaʻole nā ​​hunaola glial maʻamau, i ka radiation ʻana i ka in vitro. J Exp Ther Oncol. 2004; 4: 137-143. Nānā kiʻi ʻole.
96. Lin, S., Tsai, S. C., Lee, C. C., Wang, B. W., Liou, J. Y., a me Shyu, K. G. Berberine e kāohi i ka hōʻike HIF-1alpha ma o ka proteolysis hoʻonui ʻia. Mol Pharmacol 2004; 66: 612-619. Nānā kiʻi ʻole.
97. Nishida, S., Kikuichi, S., Yoshioka, S., Tsubaki, M., Fujii, Y., Matsuda, H., Kubo, M., a me Irimajiri, K. Hoʻokomo ʻia apoptosis i nā hunaola HL-60 i mālama ʻia. lāʻau lau nahele. 'Am J Chin Med 2003; 31: 551-562. Nānā kiʻi ʻole.
98. Iizuka, N., Oka, M., Yamamoto, K., Tangoku, A., Miyamoto, K., Miyamoto, T., Uchimura, S., Hamamoto, Y., a me Okita, K. ʻIke ʻia o nā mea maʻamau a ʻano ʻokoʻa paha. nā gen e pili ana i nā hana antitumor o kahi lau nahele lāʻau a me kāna mea nui e oligonucleotide microarray. Int J Kanesa 11-20-2003; 107: 666-672. Nānā kiʻi ʻole.
99. ʻO Jantova, S., Cipak, L., Cernakova, M., a me Kostʻalova, D. Ka hopena o berberine i ka hoʻonui ʻana, ka pōʻaiapuni a me ka apoptosis i nā pūnaewele HeLa a me L1210. ʻO J Pharm Pharmacol 2003; 55: 1143-1149. Nānā kiʻi ʻole.
100. Hong, Y., Hui, S. S., Chan, B. T., a me Hou, J. Ka hopena o berberine ma nā pae catecholamine i nāʻiole me ka hypertrophy cardiac hoʻokolohua. ʻO Life Sci. 4-18-2003; 72: 2499-2507. Nānā kiʻi ʻole.
101. ʻO Wang, DY, Yeh, CC, Lee, JH, Hung, CF, a me Chung, ʻo JG Berberine i kāohi i ka hana arylamine N-acetyltransferase a me ka hoʻākāka gen a me ka hoʻokumu adduct DNA i ka astrocytoma malignant kanaka (G9T / VGH) a me nā glioblastoma multiforms o ka lolo (GBM 8401 ) nā pūnaewele. Neurochem .Res 2002; 27: 883-889. Nānā kiʻi ʻole.
102. Sriwilaijareon, N., Petmitr, S., Mutirangura, A., Ponglikitmongkol, M., a me Wilairat, P. ʻO ke kiko kikoʻī o Plasmodium falciparum telomerase a me kāna mea kāohi ʻia e berberine. Parasitol .nt 2002; 51: 99-103. Nānā kiʻi ʻole.
103. Pan, J. F., Yu, C., Zhu, D. Y., Zhang, H., Zeng, J. F., Jiang, S. H., a me Ren, J. Y. ʻIʻike ʻia o nā metabolite sulfate-conjugated ʻekolu o ka berberine chloride i ka mimi o nā mea manawaleʻa olakino ma hope o ka hoʻoponopono waha. ʻO Acta Pharmacol Sin. 2002; 23: 77-82. Nānā kiʻi ʻole.
104. Soffar, S. A., Metwali, D. M., Abdel-Aziz, S. S., el Wakil, H. S., a me Saad, G. A. Loiloi i ka hopena o kahi alkaloid mea kanu (berberine i lawe ʻia mai Berberis aristata) ma Trichomonas vaginalis in vitro. J ʻAigupita.Soc Parasitol. 2001; 31: 893-904. Nānā kiʻi ʻole.
105. Inbaraj, J. J., Kukielczak, B. M., Bilski, P., Sandvik, S. L., a me Chignell, C. F. Photochemistry a me photocytotoxicity o alkaloids mai Goldenseal (Hydrastis canadensis L.) 1. Berberine. ʻO Chem Res Toxicol 2001; 14: 1529-1534. Nānā kiʻi ʻole.
106. Wright, C. W., Marshall, S. J., Russell, P. F., Anderson, M. M., Phillipson, J. D., Kirby, G. C., Warhurst, D. C., a me Schiff, P. L. In vitro antiplasmodial, antiamoebic, a me nā hana cytotoxic o kekahi monomeric isoquinoline alkaloids. ʻO J Nat Prod 2000; 63: 1638-1640. Nānā kiʻi ʻole.
107. Hu, J. P., Takahashi, N., a me Yamada, T. Coptidis rhizoma kaohi i ka ulu a me nā proteases o nā huaola waha. ʻO Dis. 2000; 6: 297-302. Nānā kiʻi ʻole.
108. Chung, JG, Chen, GW, Hung, CF, Lee, JH, Ho, CC, Ho, HC, Chang, HL, Lin, WC, a me Lin, JG Nā hopena o berberine ma ka arylamine N-acetyltransferase a me 2-aminofluorene- Hoʻokumu ka hoʻohui DNA i nā hunaola leukemia kanaka. ʻO Am J Chin Med 2000; 28: 227-238. Nānā kiʻi ʻole.
109. Berberine. Altern Med Rev 2000; 5: 175-177. Nānā kiʻi ʻole.
110. Iizuka, N., Miyamoto, K., Okita, K., Tangoku, A., Hayashi, H., Yosino, S., Abe, T., Morioka, T., Hazama, S., a me Oka, M. Ka hopena hoʻohiehie o Coptidis Rhizoma a me berberine i ka hoʻonui ʻia ʻana o nā lālani maʻi ʻaʻai esophageal kanaka. ʻO Lett Lett 1-1-2000; 148: 19-25. Nānā kiʻi ʻole.
111. Chae, S. H., Jeong, I. H., Choi, D. H., Oh, J. W., a me Ahn, Y. J. Ka ulu ʻana o ka hopena o Coptis japonica i loaʻa i ke aʻa isoquinoline alkaloids ma nā koʻohune ʻōpū o ke kanaka. ʻO J Agric. Meaʻai Meaʻai 1999; 47: 934-938. Nānā kiʻi ʻole.
112. Zeng, X. a me Zeng, X. Ka pilina ma waena o nā hopena maʻi o berberine i ka maikaʻi ʻole o ka puʻuwai kūpikipiki a me kona ʻano i ka plasma i hoʻopaʻa ʻia e HPLC. ʻO Biomed Chromatogr 1999; 13: 442-444. Nānā kiʻi ʻole.
113. Lin, J. G., Chung, J. G., Wu, L. T., Chen, G. W., Chang, H. L., a me Wang, T. F. Nā hopena o berberine ma ka hana ʻana o arylamine N-acetyltransferase i loko o nā hunaola tumele kolone kanaka. 'Am J Chin Med 1999; 27: 265-275. Nānā kiʻi ʻole.
114. Chung, JG, Wu, LT, Chu, CB, Jan, JY, Ho, CC, Tsou, MF, Lu, HF, Chen, GW, Lin, JG, a me Wang, TF Nā hopena o berberine ma arylamine N-acetyltransferase hana i nā hunaola tumeke kanaka. Nūhou Chem Toxicol 1999; 37: 319-326. Nānā kiʻi ʻole.
115. ʻO Wu, H. L., Hsu, C. Y., Liu, W. H., a me Yung, B. Y. ʻO Berberine i hoʻokomo ʻia apoptosis o ka leukemia kanaka HL-60 pūnaewele e pili pū me ka hoʻomalu o ka nucleophosmin / B23 a me ka hana telomerase. Int J Kanesa 6-11-1999; 81: 923-929. Nānā kiʻi ʻole.
116. ʻO Sun D, ​​ʻo Courtney HS, a ʻo Beachey EH. Palaka ʻo Berberine sulfate i ka paʻa ʻana o Streptococcus pyogenes i nā hunaola epithelial, fibronectin, a me hexadecane. Nā Antimicrobial Agents a me Chemotherapy 1988; 32: 1370-1374.
117. Palasuntheram C, Iyer KS, de Silva LB, a me et al. ʻO ka hana Antibacterial o Coscinium fenestratum Colebr e kūʻē iā Clostridium tetani. Ind J Med Res 1982; 76 (Hōʻawi): 71-76.
118. ʻO Zhu B lāua ʻo Ahrens FA. Ka hopena o berberine ma ka huna ʻōpū i hoʻopili ʻia e Escherichia coli enterotoxin wela-paʻa i jejunum o nā puaʻa. ʻO Am J Vet Res 1982; 43: 1594-1598.
119. ʻO Supek Z lāua ʻo Tomic D. Farmakološko-kemijsko istrazivanje zutike (
120. ʻO Zalewski A, Krol R, a me Maroko PR. ʻO Berberine, kahi agena inotropic hou - hoʻokaʻawale ma waena o kāna naʻau a me nā pane ākea. ʻOihana Res 1983; 31: 227A.
121. Krol R, Zalewski A, a me Maroko PR. Nā hopena maikaʻi o berberine, kahi mea inotropic maikaʻi hou, ma nā arrhythmia ventricular i hoʻokomo ʻia digitalis. Kaapuni 1982; 66 (sup 2): 56.
122. ʻO Subbaiah TV a me Amin AH. Ka hopena o ka berberine sulphate ma Entamoeba histolytica. Kūlohelohe 1967; 215: 527-528.
123. Kaneda Y, Tanaka T, a me Saw T. Nā hopena o berberine, kahi alkaloid mea kanu, i ka ulu ʻana o anaerobic protozoa i ka moʻomeheu axenic. ʻO Tokai J Exp Clin Med 1990; 15: 417-423.
124. ʻO Ghosh AK, Bhattacharyya FK, a me Ghosh DK. Leishmania donovani: ka pāpā amastigote a me ke ʻano o ka hana o berberine. Parasitology Hoʻokolohua 1985; 60: 404-413.
125. Sabir M, Mahajan VM, Mohapatra LN, a me et al. Ke aʻo hoʻokolohua o ka hana antitrachoma o berberine. ʻO Indian J Med Res 1976; 64: 1160-1167.
126. ʻO Seery TM a me Bieter RN. ʻO kahi haʻawina i ka lāʻau lapaʻau o berberine. ʻO J Pharmacol Exp Ther 1940; 69: 64-67.
127. ʻO Tripathi YB a me Shukla SD. Ke kāohi nei ʻo Berberis artistata i ka hoʻopili ʻana o PAF i nā pāpaʻi lāpaki. ʻImi Phytotherapy 1996; 10: 628-630.
128. ʻO Sabir M lāua ʻo Bhide NK. Ke aʻo ʻana i kekahi mau hana pharmacological o berberine. Ind J Physiol & Pharmac 1971; 15: 111-132.
129. Chung JG, Wu LT, Chang SH, a me et al. Nā hana kaohi o berberine i ka ulu a me ka arylamine N-acetyltransferase i nā ʻano o Helicobacter Pylori mai nā mea maʻi ulia peptic. Ka Nūpepa International o Toxicology 1999; 18: 35.
130. ʻO Sharda DC. ʻO Berberine i ka mālama ʻana i ka maʻi kōkō o ka wā pēpē a me ke keiki. ʻO J Indian M A 1970; 54: 22-24.
131. Vik-Mo H, Faria DB, Cheung WM, a me et al. Nā hopena maikaʻi o berberine ma ka hana hema ventricular i nā ʻīlio me ka puʻuwai ʻole. Nānā Lapaʻau 1983; 31: 224a.
132. Ksiezycka E, Cheung W, a me Maroko PR. Nā hopena Antiarrhythmic o berberine ma aconitine-hoʻokomo ʻia ventricular a me supraventricular arrhythmia. Nānā Lapaʻau 1983; 31: 197A.
133. Seow WK, Ferrante A, Hōʻuluʻulu A, a me et al. Nā hopena hoʻohālikelike o tetrandrine a me berbamine i ka hana ʻana o ka cytokines inflammatory interleukin-1 a me ka tumzrosros tumrosis factor. Nā Koina Ola 1992; 50: pl-53-pl-58.
134. Peng, W. H., Hsieh, M. T., a me Wu, C. R. Ka hopena o ka lawelawe wā lōʻihi o berberine ma amnesia i hoʻokomo ʻia scopolamine i nāʻiole. ʻO Jpn J Pharmacol 1997; 74: 261-266. Nānā kiʻi ʻole.
135. Wu, J. F. a me Liu, T. P. [Nā hopena o berberine ma ka hōʻiliʻili platelet a me nā pae plasma o TXB2 a me 6-keto-PGF1 alpha i nāʻiole me ka hoʻoliʻiliʻi waena o ke aʻa kūwaho hoʻi]. Yao Xue.Xue.Bao. 1995; 30: 98-102. Nānā kiʻi ʻole.
136. Yuan, J., Shen, X. Z., a me Zhu, X. S. [Ka hopena o berberine i ka manawa hele o ka ʻōpū liʻiliʻi o ke kanaka]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1994; 14: 718-720. Nānā kiʻi ʻole.
137. Muller, K., Ziereis, K., a me Gawlik, I. ʻO ka antipsoriatic Mahonia aquifolium a me kāna mau mea hana; II. ʻO ka hana antiproliferative e kūʻē i ka ulu ʻana o nā keratinocytes kanaka. Planta Med 1995; 61: 74-75. Nānā kiʻi ʻole.
138. Swabb, E. A., Tai, Y. H., a me Ioredane, L. Reversal o ka cholera toxin-induced secretion i ka rat ileum e luminal berberine. 'Am J Physiol 1981; 241: G248-G252. Nānā kiʻi ʻole.
139. ʻO Sack, R. B. a me Froehlich, ua kāohi ʻo J. L. Berberine i ka pane ʻōpū o Vibrio cholerae a me Escherichia coli enterotoxins. Immun Immun. 1982; 35: 471-475. Nānā kiʻi ʻole.
140. Zhu, B. a me Ahrens, F. Nā hopena antisecretory o berberine me ka morphine, clonidine, L-phenylephrine, yohimbine a i ʻole neostigmine i ka jejunum puaʻa. Eur J Pharmacol 12-9-1983; 96 (1-2): 11-19. Nānā kiʻi ʻole.
141. Shanbhag, S. M., Kulkarni, H. J., a me Gaitonde, B. B. Nā hana Pharmacological o berberine ma ke kikowaena pūnaewele koʻikoʻi. Jpn.J Pharmacol 1970; 20: 482-487. Nānā kiʻi ʻole.
142. Choudhry, V. P., Sabir, M., a me Bhide, V. N. Berberine ma giardiasis. ʻO Pediatr India. 1972; 9: 143-146. Nānā kiʻi ʻole.
143. Kulkarni, S. K., Dandiya, P. C., a me Varandani, N. L. Nānā i nā lāʻau lapaʻau o berberine sulphate. Jpn.J Pharmacol. 1972; 22: 11-16. Nānā kiʻi ʻole.
144. ʻO Marin-Neto, J. A., Maciel, B. C., Secches, A. L., a me Gallo, Junior L. Cardiovascular hopena o berberine i nā mea maʻi me ka maikaʻi ʻole o ka puʻuwai puʻuwai. ʻO Clin.Cardiol. 1988; 11: 253-260. Nānā kiʻi ʻole.
145. Ni, Y. X. [Ka hopena therapeutic o berberine ma 60 mau maʻi me ka type II diabetes mellitus a me ka noiʻi hoʻokolohua]. Zhong.Xi.Yi.Jie.He.Za Zhi.- Ka Puke Haʻi Haina o nā Hoʻolālā Hou i ka Lapaʻau Kuʻuna 1988; 8: 711-3, 707. Nānā i nā abstract.
146. Zhang, M. F. a me Shen, Y. Q. [Antidiarrheal a me nā hopena anti-inflammatory o berberine]. Zhongguo Yao Li Xue.Bao. 1989; 10: 174-176. Nānā kiʻi ʻole.
147. ʻO Shaffer, J. E. Inotropic a me ka hana Chronotropic o berberine ma atrian guinea pig. ʻO J Cardiovasc Pharmacol 1985; 7: 307-315. Nānā kiʻi ʻole.
148. Huang, W. M., Wu, Z. D., a me Gan, Y. Q. [Nā hopena o berberine ma ka ischemic ventricular arrhythmia]. Zhonghua Xin.Xue.Guan.Bing.Za Zhi. 1989; 17: 300-1, 319. E nānā abstract.
149. Huang, W.[Hoʻomaʻamaʻa ʻia nā tachyarrhythmias Ventricular me ka berberine]. Zhonghua Xin.Xue.Guan.Bing.Za Zhi. 1990; 18: 155-6, 190. Nānā i ka abstract.
150. Hui, K. K., Yu, J. L., Chan, W. F., a me Tse, E. Ka launa pū ʻana o berberine me ka platelet kanaka alpha 2 adrenoceptors. ʻO Life Sci. 1991; 49: 315-324. Nānā kiʻi ʻole.
151. Freile, ML, Giannini, F., Pucci, G., Sturniolo, A., Rodero, L., Pucci, O., Balzareti, V., a me Enriz, RD Antimicrobial activity of aqueous extract and of berberine isolated from Berberis heterophylla . Fitoterapia 2003; 74 (7-8): 702-705. Nānā kiʻi ʻole.
152. Khin, Maung U. a me Nwe, Nwe Wai. Ka hopena o berberine ma ka enterotoxin-i hoʻokomo ʻia i ka hoʻoulu wai i loko o nāʻiole. ʻO J Diarrheal Dis Res 1992; 10: 201-204. Nānā kiʻi ʻole.
153. ʻO Hajnicka, V., Kostʻalova, D., Svecova, D., Sochorova, R., Fuchsberger, N., a me Toth, J. Ka hopena o Mahonia aquifolium e hoʻopili ana i nā hui interleukin-8 i ka laina cell monosittic THP. -1. Planta Med 2002; 68: 266-268. Nānā kiʻi ʻole.
154. Lau, C. W., Yao, X. Q., Chen, Z. Y., Ko, W. H., a me Huang, Y. Cardiovascular hana o berberine. ʻO Cardiovasc Drug Rev 2001; 19: 234-244. Nānā kiʻi ʻole.
155. Mitani, N., Murakami, K., Yamaura, T., Ikeda, T., a me Saiki, I ka hopena o ka berberine ma ka metastasis lymph node metastasis i hana ʻia e ka orthotopic implantation o ka maʻi maʻi ʻo Lewis. Kāpena Lett. 4-10-2001; 165: 35-42. Nānā kiʻi ʻole.
156. Fukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., a me Fujiwara, H. Inhibition na berberine o cyclooxygenase-2 hana transcriptional i nā kolamu maʻi ʻaʻai kolone kanaka. ʻO J Ethnopharmacol. 1999; 66: 227-233. Nānā kiʻi ʻole.
157. Li, H., Miyahara, T., Tezuka, Y., Namba, T., Suzuki, T., Dowaki, R., Watanabe, M., Nemoto, N., Tonami, S., Seto, H., a me Kadota, S. Ka hopena o ka hoʻomoʻomoʻi kampo ma ka resorption iwi i vitro a me in vivo. II. Ke aʻo piha o berberine. Biol Pharm Bull 1999; 22: 391-396. Nānā kiʻi ʻole.
158. Abe, F., Nagafuji, S., Yamauchi, T., Okabe, H., Maki, J., Higo, H., Akahane, H., Aguilar, A., Jimenez-Estrada, M., and Reyes- ʻO Chilpa, R. Trypanocidal nā mea pili i nā mea kanu 1. Ka loiloi ʻana i kekahi mau mea kanu Mekiko no kā lākou hana trypanocidal a me nā mea paʻa i Guaco, nā aʻa o Aristolochia taliscana. Biol Pharm Bull 2002; 25: 1188-1191. Nānā kiʻi ʻole.
159. ʻO Chatterjee P, Franklin MR. ʻO ka pākino cytochrome p450 kanaka a me ka metabolic-waena waena paʻakikī e ka goldenseal extract a me nā methylenedioxyphenyl. Ka Waihona Metab Lapaʻau 2003; 31: 1391-7. Nānā kiʻi ʻole.
160. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. ʻO kahi loiloi in vitro o ke kanaka cytochrome P450 3A4 kaohi e nā mea kanu lāʻau a me nā tincture i koho ʻia. Phytomedicine 2000; 7: 273-82. Nānā kiʻi ʻole.
161. Huang XS, Yang GF, Pan YC. Ka hopena o berberin hydrochloride ma ke kahe o ke koko o cyclosporine A i nā mea maʻi transplanted cardiac. Zhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28: 702-4. Nānā kiʻi ʻole.
162. Zhang Y, Li X, Zou D, et al. Ka mālama ʻana i ka maʻi diabetes type 2 a me ka dislipidemia me ka berberine alkaloid maoli. ʻO J Clin Endocrinol Metab 2008; 93: 2559-65. Nānā kiʻi ʻole.
163. ʻO Cicero, AF, Rovati LC, a me Setnikar I. Nā hopena Eulipidemic o berberine i lawelawe hoʻokahi ʻia a i ʻole me nā hui ʻemi hoʻohaʻahaʻa kolesterol maoli. ʻO kahi hoʻokolokolo hoʻokolohua makapō hoʻokahi. Arzneimittelforschung. 2007; 57: 26-30. Nānā kiʻi ʻole.
164. Vollekova A, Kostʻalova D, Kettmann V, Toth J. Antifungal hana o Mahonia aquifolium extract a me kāna nui protoberberine alkaloids. Phytother Res 2003; 17: 834-7. Nānā kiʻi ʻole.
165. Kim SH, Shin DS, Oh MN, et al. ʻO ka pāpā ʻana o ka iʻaola i kū i ka protein i heleuma i transposidase sortase na isoquinoline alkaloids. Biosci Biotechnol Biochem 2004; 68: 421-4 .. Nānā i ka abstract.
166. Li B, Shang JC, Zhou QX. [Ke aʻo ʻana i nā alkaloid āpau mai rhizoma coptis chinensis ma nā ulia gastric hoʻokolohua]. Chin J Integr Med 2005; 11: 217-21. Nānā kiʻi ʻole.
167. ʻO Ivanovska N, ʻo Philipov S. Ke aʻo ʻana ma ka hana anti-inflammatory o Berberis vulgaris root extract, nā hapa alkaloid a me nā alkaloid maʻemaʻe. Int J Immunopharmacol 1996; 18: 553-61. Nānā kiʻi ʻole.
168. Ang ES, Lee ST, Gan CS, et al. Ke loiloi nei i ke kuleana o kahi lāʻau ʻē aʻe i ka mālama ʻana i ka ʻeha. MedGenMed 2001; 3: 3. Nānā kiʻi ʻole.
169. ʻO Tsai PL, ʻo Tsai TH. Hoʻopau Hepatobiliary o berberine. ʻO ka Dispat Metab Pūnaewele 2004; 32: 405-12. . Nānā kiʻi ʻole.
170. ʻO Wu X, Li Q, Xin H, Yu A, Zhong M. Nā hopena o berberine i ke kahe o ke koko o cyclosporin A i nā mea i loaʻa i nā transplanted: clinical and pharmacokinetic study. Eur J Clin Pharmacol 2005; 61: 567-72. Nānā kiʻi ʻole.
171. Khosla PG, Neeraj VI, Gupta SK, et al. ʻO Berberine, kahi lāʻau kūpono no trachoma. ʻO Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 1992; 69: 147-65. Nānā kiʻi ʻole.
172. Hsiang CY, Wu SL, Cheng SE, Ho TY. Hoʻokipa ʻia ʻo Acetaldehyde interleukin-1beta a me ka tumzrosz factor-alpha hana e ka berberine ma o ka nukleona-kappaB ala hōʻailona ma nā hunaola HepG2. ʻO J Biomed Sci 2005; 12: 791-801. Nānā kiʻi ʻole.
173. Anis KV, Rajeshkumar NV, Kuttan R. Ka pāpā ʻana i ka carcinogenesis kemika na berberine i nāʻiole a me nāʻiole. ʻO J Pharm Pharmacol 2001; 53: 763-8. . Nānā kiʻi ʻole.
174. Zeng XH, Zeng XJ, Li YY. Ka maikaʻi a me ka palekana o berberine no ka puʻuwai puʻuwai congestive kekona i ka ischemic a i ʻole idiopathic dilated cardiomyopathy. 'Am J Cardiol 2003; 92: 173-6. Nānā kiʻi ʻole.
175. Janbaz KH, Gilani AH. ʻO nā haʻawina e pili ana i nā hopena pale a me nā curative o berberine ma ka hepatotoxicity i hoʻokomo ʻia i ka kemikona i nā koʻokoʻo. Fitoterapia 2000; 71: 25-33 .. Nānā i ka abstract.
176. Fukuda K, Hibiya Y, Mutoh M, et al. Ka pāpā ʻia e berberine o ka cyclooxygenase-2 hana transcriptional i loko o nā hunaola maʻi ʻaʻai kolone kanaka. ʻO J Ethnopharmacol 1999; 66: 227-33. Nānā kiʻi ʻole.
177. Park KS, Kang KC, Kim JH, et al. Nā hopena hoʻohiehie ʻokoʻa o nā protoberberines ma sterol a me chitin biosyntheses ma Candida albicans. ʻO J Antimicrob Chemother 1999; 43: 667-74. Nānā kiʻi ʻole.
178. Kim JS, Tanaka H, ​​Shoyama Y. Ka nānā pono ʻole Immunoquantitative no berberine a me nā mea e pili ana i ka hoʻohana ʻana i nā antibodies monoclonal i nā lāʻau lapaʻau. Nānā 2004; 129: 87-91. Nānā kiʻi ʻole.
179. ʻO Scazzocchio F, Corneta MF, Tomassini L, Palmery M. Hana Antibacterial o Hydrastis canadensis extract a me kāna mau alkaloid kaʻawale nui. Planta Med 2001; 67: 561-4. Nānā kiʻi ʻole.
180. ʻO Sun D, ​​Courtney HS, Beachey EH. Palaka ʻo Berberine sulfate i ka paʻa ʻana o Streptococcus pyogenes i nā hunaola epithelial, fibronectin, a me hexadecane. Nā Antimicrob Agents Chemother 1988; 32: 1370-4. Nānā kiʻi ʻole.
181. Amin AH, Subbaiah TV, Abbasi KM. Berberine sulfate: hana antimicrobial, bioassay, a me ke ʻano o ka hana. Hiki iā J Microbiol 1969; 15: 1067-76. Nānā kiʻi ʻole.
182. Bhide MB, Chavan SR, Dutta NK. Hoʻomaʻamaʻa, hāʻawi a hāʻawi ʻana i ka berberine. ʻO Indian J Med Res 1969; 57: 2128-31. Nānā kiʻi ʻole.
183. Chan E. Hoʻoneʻe i ka bilirubin mai albumin na berberine. ʻO Biol Neonate 1993; 63: 201-8. Nānā kiʻi ʻole.
184. Gupte S. Hoʻohana o berberine i ka mālama ʻana i ka giardiasis. ʻO Am J Dis Child 1975; 129: 866. Nānā kiʻi ʻole.
185. Kaneda Y, Torii M, Tanaka T, Aikawa M. Nā hopena vitro o berberine sulphate i ka ulu a me ke kūkulu ʻana o Entamoeba histolytica, Giardia lamblia a me Trichomonas vaginalis. Ann Trop Med Parasitol 1991; 85: 417-25. Nānā kiʻi ʻole.
186. ʻO Sun D, ​​ʻAberahama SN, Beachey EH. Ka hopena o berberine sulfate ma ke synthesis a me ka hōʻike o ka pap fimbrial adhesin i ka uropathogenic Escherichia coli. Nā Antimicrob Agents Chemother 1988; 32: 1274-7. Nānā kiʻi ʻole.
187. Rehman J, Dillow JM, Carter SM, et al. Hoʻonui i ka hana o nā immunoglobulins kikoʻī antigen a me M e ukali nei i ka mālama vivo me nā mea kanu lāʻau ʻo Echinacea angustifolia a me Hydrastis canadensis. ʻO Immunol Lett 1999; 68: 391-5. Nānā kiʻi ʻole.
188. Sheng WD, Jiddawi MS, Hong XQ, Abdulla SM. ʻO ka mālama ʻana i ka malaria chloroquine kūpaʻa e hoʻohana ana i ka pyrimethamine me ka berberine, tetracycline, a i ʻole cotrimoxazole. East Afr Med J 1997; 74: 283-4. Nānā kiʻi ʻole.
189. Rabbani GH, Butler T, Knight J, et al. Hoʻomaʻamaʻa kaulike ʻia o ka berberine sulfate therapy no ka maʻi diarrhea ma muli o enterotoxigenic Escherichia coli a me Vibrio cholerae. ʻO J Infect Dis 1987; 155: 979-84. Nānā kiʻi ʻole.
190. ʻO Tyler VE. Nā mea kanu o ke koho. Binghamton, NY: Hale Paʻi Mea Pono Mea Pono, 1994.
191. Blumenthal M, ed. ʻO ke Komikina Kelemania E Monographs: Alakaʻi Therapeutic i nā lāʻau Laʻau. Trans. S. Klein. ʻO Boston, MA: ʻAmelika Botanical Council, 1998.
192. ʻO nā monograps e pili ana i nā lāʻau lapaʻau o nā mea kanu lāʻau. Exeter, UK: ʻEpekema ʻEpekema Co-op Phytother, 1997.

Nānā hope - 01/26/2021